Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 19 Prostatic Neoplasms 9 Polycystic Ovary Syndrome 7 Vitamin D Deficiency 6 Osteoporosis 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms 4 Colonic Neoplasms 4 Obesity 3 Inflammation 3 Colorectal Neoplasms 3 Bone Diseases, Metabolic 3 Neoplasm Metastasis 2 Multiple Endocrine Neoplasia Type 1 2 Motor Activity 2 Lymphoma 2 Lung Neoplasms 2 Leukemia 2 Gastrointestinal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Warts 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Solid Cancers 1

Interventions

nintedanib 1 Vitamin D 1 Surveys and Questionnaires 1 Paclitaxel 1 Eye Movement Desensitization Reprocessing 1 Electrochemotherapy 1 Cholecalciferol 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Melanoma, Cutaneous Malignant × Vitamin D × Clear all

NCT01748448 2025-02-17

ViDMe

Universitaire Ziekenhuizen KU Leuven

Phase 3 Completed

436 enrolled 16 charts

Melanoma, Cutaneous Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡